Drugs / L2SN
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00004454 | Oct 1996 → ? | mucopolysaccharidosis type 2 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L2SN | “Determine the levels of iduronate-2-sulfatase enzyme in these patients attained by infusing increasing doses of lymphocytes transduced with a retroviral vector designed for...” NCT00004454 ↗ |
| Action | Restore | “designed for insertion and expression of this iduronate-2-sulfatase gene” NCT00004454 ↗ |